US Congress House Bill 1035 (Prior Session Legislation)

---

Spectrum: Slight Partisan Bill (Republican 26-13)
Status: Introduced on February 7 2019 - 25% progression, died in committee
Action: 2019-02-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Establishes additional requirements for prescription drug plan sponsors (PDPs) under Medicare and Medicare Advantage, as well as health insurance carriers under the Federal Employees Health Benefits Program, relating to the methodology of payments to pharmacies and the use of pharmacy benefits managers (PBMs). Specifically, such PDPs and carriers must disclose specified information to pharmacies regarding applicable standards for reimbursement that are based on drug costs, including the sources used to update such standards. Additionally, such PDPs and carriers may not contract with PBMs that require, or that provide an incentive for, plan enrollees to use pharmacies that have a shared ownership interest with the PBM.

Prescription Drug Price Transparency Act

Rep. Doug Collins [R-GA]	Rep. David Loebsack [D-IA]	Rep. David Roe [R-TN]	Rep. Bruce Westerman [R-AR]
Rep. Kathleen Rice [D-NY]	Rep. Steve King [R-IA]	Rep. Yvette Clarke [D-NY]	Rep. Austin Scott [R-GA]
Rep. Jody Hice [R-GA]	Rep. Filemon Vela [D-TX]	Rep. Jamie Raskin [D-MD]	Rep. Cathy McMorris Rodgers [R-WA]
Sen. Peter Welch [D-VT]	Rep. Earl Carter [R-GA]	Rep. Eric Crawford [R-AR]	Rep. Collin Peterson [D-MN]
Rep. Bradley Byrne [R-AL]	Rep. Dan Newhouse [R-WA]	Rep. Jaime Herrera Beutler [R-WA]	Rep. Vicente Gonzalez [D-TX]
Sen. Roger Marshall [R-KS]	Rep. Steven Palazzo [R-MS]	Sen. Ted Budd [R-NC]	Rep. Martha Roby [R-AL]
Rep. Lloyd Doggett [D-TX]	Rep. Mo Brooks [R-AL]	Rep. French Hill [R-AR]	Rep. Sharice Davids [D-KS]
Rep. Peter Visclosky [D-IN]	Rep. Barry Loudermilk [R-GA]	Rep. Dan Meuser [R-PA]	Rep. Tulsi Gabbard [D-HI]
Rep. Mike D. Rogers [R-AL]	Rep. John Sarbanes [D-MD]	Rep. Ben Cline [R-VA]	Rep. Bill Posey [R-FL]
Rep. Debbie Lesko [R-AZ]	Rep. Fred Keller [R-PA]	Rep. Glenn Thompson [R-PA]

Date	Chamber	Action
2019-02-07	House	Referred to the Subcommittee on Health.
2019-02-07	House	Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-07	House	Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-07	House	Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-07	House	Introduced in House

HB1332 (Related) 2019-02-26 - Referred to the Subcommittee on Health.
SB4796 (Related) 2020-10-05 - Read twice and referred to the Committee on Finance.
HB8527 (Related) 2020-10-02 - Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, the Judiciary, Oversight and Reform, House Administration, Rules, the Budget, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/house-bill/1035/all-info
Text	https://www.congress.gov/116/bills/hr1035/BILLS-116hr1035ih.pdf